CAS RN: 95-26-1
2,5-Dimethylbenzothiazole
Product Availability
Choose a grade to view its available package options.
2 package records 2 with current stock 1 grade group
Grade
98% (2)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20260410
1g
In stock
Shanghai, Guangdong, Hebei Inquiry
Batchno.20250307
250mg
In stock
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 95-26-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Shenzhen
Inquiry
95-26-1 / 2,5-dimethyl-1,3-benzothiazole
Standard CAS: 95-26-1
Multi CAS: Yes
Basic Information
copy
CAS
95-26-1 copy
Multi CAS
Yes copy
Molecular Formula
C9H9NS copy
Molecular Weight
163.240000 copy
Exact Mass
163.045570 copy
InChI
InChI=1S/C9H9NS/c1-6-3-4-9-8(5-6)10-7(2)11-9/h3-5H,1-2H3 copy
InChIKey
XHANCLXYCNTZMM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.22 copy
H-bond acceptors
2 copy
Molar refractivity
49.09 copy
TPSA
12.89 copy
LogP / Solubility
WLOGP
2.91 copy
MLOGP
2.56 copy
XLogP3
3.1 copy
Consensus LogP
2.86 copy
Log S (ESOL)
-3.29 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.14 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.65 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy